statistiche ricercatore

Continente	#
NA - Nord America	998
EU - Europa	994
AS - Asia	433
SA - Sud America	62
Continente sconosciuto - Info sul continente non disponibili	38
AF - Africa	25
OC - Oceania	1
Totale	2.551

Nazione	#
US - Stati Uniti d'America	980
IT - Italia	286
RU - Federazione Russa	198
GB - Regno Unito	197
SG - Singapore	123
CN - Cina	117
IE - Irlanda	99
VN - Vietnam	66
BR - Brasile	53
FR - Francia	42
SE - Svezia	40
DE - Germania	34
FI - Finlandia	31
HK - Hong Kong	31
UA - Ucraina	23
KR - Corea	18
IN - India	17
NL - Olanda	12
BE - Belgio	11
ZA - Sudafrica	11
BD - Bangladesh	9
TR - Turchia	9
CA - Canada	7
MX - Messico	7
JP - Giappone	6
AR - Argentina	5
AT - Austria	5
ID - Indonesia	5
IQ - Iraq	5
ES - Italia	4
NG - Nigeria	4
NP - Nepal	4
PK - Pakistan	4
CH - Svizzera	3
CI - Costa d'Avorio	3
KE - Kenya	3
KZ - Kazakistan	3
CZ - Repubblica Ceca	2
IL - Israele	2
MA - Marocco	2
MY - Malesia	2
UZ - Uzbekistan	2
AE - Emirati Arabi Uniti	1
AZ - Azerbaigian	1
BN - Brunei Darussalam	1
CL - Cile	1
CR - Costa Rica	1
CY - Cipro	1
EC - Ecuador	1
EE - Estonia	1
IR - Iran	1
JM - Giamaica	1
KH - Cambogia	1
LV - Lettonia	1
MD - Moldavia	1
MN - Mongolia	1
NO - Norvegia	1
NZ - Nuova Zelanda	1
PA - Panama	1
PH - Filippine	1
PL - Polonia	1
RO - Romania	1
SA - Arabia Saudita	1
SC - Seychelles	1
SK - Slovacchia (Repubblica Slovacca)	1
SV - El Salvador	1
TH - Thailandia	1
TN - Tunisia	1
UY - Uruguay	1
VE - Venezuela	1
Totale	2.513

Nome	#
p66Shc deficiency in the Eμ-TCL1 mouse model of chronic lymphocytic leukemia enhances leukemogenesis by altering the chemokine receptor landscape	395
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients	375
A novel class of oxazepine-based anti-cancer agents induces cell death in primary human CLL cells and efficiently reduces tumor growth in Eμ-TCL1 mice through the JNK/STAT4/p66Shc axis	341
Ectopic ILT3 controls BCR-dependent activation of Akt in B-cell chronic lymphocytic leukemia	283
Human cytotoxic T lymphocytes form dysfunctional immune synapses with B cells characterized by non-polarized lytic granule release	274
Unravelling the response of chronic lymphocytic leukemia to a novel class of anticancer agents, the pyrrolonaphthoxazepines (PNOXs)	273
Signals controlling lytic granule polarization at the cytotoxic immune synapse	235
Apoliprotein E-mediated ferroptosis controls cellular proliferation in chronic lymphocytic leukemia	214
Assessing gene function in human B cells: CRISPR/Cas9-based gene editing and mRNA-based gene expression in healthy and tumor cells	138
Monoclonal antibodies protect against pandrug-resistant Klebsiella pneumoniae	23
Totale	2.551

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	169	0	18	10	7	25	10	10	11	4	13	27	34
2022/2023	197	9	26	19	26	23	30	8	11	21	8	15	1
2023/2024	191	4	4	26	13	11	42	65	8	0	4	8	6
2024/2025	383	14	20	60	12	34	28	16	37	18	26	45	73
2025/2026	963	56	115	137	136	184	32	101	23	33	50	35	61
2026/2027	55	37	18	0	0	0	0	0	0	0	0	0	0
Totale													2.551